SecSonar.com

Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Armata Pharmaceuticals, Inc. (ARMP) is a Biotechnology company based in US with a market capitalization of $300.3M. Revenue declined 5.2% year-over-year and free cash flow was negative at -$26.3M. This page tracks ARMP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 60 employees · IPO May 20, 1994

Valuation

Valuation & price

$8.05 · as of May 17, 2026 · -45.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$13.91$7.97$2.04Jul 25Dec 25Jul 26Jul 7, 25$2.04Jul 9, 25$2.22Jul 11, 25$2.22Jul 15, 25$2.46Jul 17, 25$2.42Jul 21, 25$2.38Jul 23, 25$2.40Jul 25, 25$2.39Jul 29, 25$2.43Jul 31, 25$2.45Aug 4, 25$2.71Aug 6, 25$2.59Aug 11, 25$2.36Aug 13, 25$2.50Aug 15, 25$2.55Aug 19, 25$2.54Aug 21, 25$2.43Aug 25, 25$2.60Aug 27, 25$2.44Aug 29, 25$2.50Sep 3, 25$3.00Sep 5, 25$2.85Sep 9, 25$2.95Sep 11, 25$2.96Sep 16, 25$2.88Sep 18, 25$2.98Sep 22, 25$3.02Sep 24, 25$3.07Sep 26, 25$3.01Sep 30, 25$2.98Oct 2, 25$3.07Oct 6, 25$3.20Oct 8, 25$3.22Oct 10, 25$3.17Oct 14, 25$3.28Oct 16, 25$3.49Oct 21, 25$3.47Oct 23, 25$7.10Oct 27, 25$5.27Oct 29, 25$5.46Oct 31, 25$4.91Nov 4, 25$4.84Nov 6, 25$5.74Nov 10, 25$6.21Nov 12, 25$6.69Nov 14, 25$7.32Nov 18, 25$6.88Nov 20, 25$7.15Nov 25, 25$7.10Nov 28, 25$7.33Dec 2, 25$5.31Dec 4, 25$5.94Dec 8, 25$5.50Dec 10, 25$5.67Dec 12, 25$5.90Dec 16, 25$5.72Dec 18, 25$5.40Dec 22, 25$6.37Dec 24, 25$6.41Dec 29, 25$6.36Jan 2, 26$6.56Jan 6, 26$5.87Jan 8, 26$7.89Jan 12, 26$6.68Jan 14, 26$5.70Jan 16, 26$6.40Jan 21, 26$5.98Jan 23, 26$6.00Jan 27, 26$6.59Jan 29, 26$6.64Feb 2, 26$7.74Feb 4, 26$8.10Feb 9, 26$7.82Feb 11, 26$8.00Feb 13, 26$8.15Feb 18, 26$8.09Feb 20, 26$8.73Feb 24, 26$11.86Feb 26, 26$10.83Mar 2, 26$11.42Mar 4, 26$11.61Mar 6, 26$10.60Mar 10, 26$11.96Mar 12, 26$10.63Mar 17, 26$9.61Mar 19, 26$8.29Mar 23, 26$8.09Mar 25, 26$8.61Mar 27, 26$8.37Mar 31, 26$10.24Apr 2, 26$10.18Apr 7, 26$11.95Apr 9, 26$11.53Apr 13, 26$11.69Apr 15, 26$12.06Apr 17, 26$11.50Apr 22, 26$13.91Apr 24, 26$12.92Apr 28, 26$9.76Apr 30, 26$9.98May 4, 26$9.85May 6, 26$9.06May 8, 26$8.30May 12, 26$9.00May 14, 26$8.20May 18, 26$7.60May 20, 26$8.12May 22, 26$8.36May 28, 26$8.12Jun 1, 26$7.80Jun 3, 26$7.59Jun 5, 26$7.50Jun 9, 26$7.78Jun 11, 26$7.47Jun 15, 26$6.91Jun 17, 26$7.06Jun 22, 26$6.87Jun 24, 26$7.35Jun 26, 26$7.40Jul 2, 26$5.89
$2.0452-week range$14.80
Loading valuation history…

Fundamentals

Key fundamentals

$300.3M

Market cap

-5.2%

Revenue growth (YoY)

68.8%

Gross margin

-$26.3M

Free cash flow (USD)

$279.3M

Net debt

0.2%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$260.0KFY 2017$115.0KFY 2018$0.00FY 2019$0.00FY 2020$823.0KFY 2021$4.5MFY 2022$5.5MFY 2023$4.5MFY 2024$5.2MFY 2025$4.9M
$260K$4.9M

Free cash flow by year

2016 → 2025

FY 2016$-10.9MFY 2017$-9.3MFY 2018$-9.4MFY 2019$-15.7MFY 2020$-19.1MFY 2021$-24.9MFY 2022$-34.7MFY 2023$-55.6MFY 2024$-39.4MFY 2025$-26.3M
-$10.9M-$26.3M

Gross margin by year

2021 → 2025

FY 2021-347.4%FY 2022-535.8%FY 202378.5%FY 2024-565.4%FY 202568.8%
-347.4%68.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard Committee AssignmentJun 24, 2026Filing
  • 8-K eventFunding Award ReceivedJun 23, 2026Filing
  • 8-K eventAnnual Shareholder MeetingJun 16, 2026Filing
  • 8-K eventCredit Agreement ExecutedMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventFDA Fast Track DesignationMay 7, 2026Filing
  • 8-K eventDirector AppointmentApr 27, 2026Filing
  • 8-K eventAnnual Meeting ScheduledApr 2, 2026Filing

Questions

Frequently asked questions

What is Armata Pharmaceuticals, Inc.'s market cap?

Armata Pharmaceuticals, Inc. (ARMP) has a market capitalization of $300.3M.

What is ARMP's P/E ratio?

A meaningful P/E ratio is not available for ARMP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying ARMP stock?

SEC Form 4 filings show no open-market insider buys at Armata Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

AMRN

Amarin Corporation plc

$302.3M

VSTM

Verastem, Inc.

$303.9M

ENTA

Enanta Pharmaceuticals, Inc.

$305.7M

XOMAP

XOMA Corporation

$307M

ZNTL

Zentalis Pharmaceuticals, Inc.

$290.7M

NAGE

Niagen Bioscience Inc

$311.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.